NCT00945841View on ClinicalTrials.gov

Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010

PHASE3CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Seasonal Influenza
Interventions
BIOLOGICAL

inactivated split influenza vaccine

1 dose of inactivated split influenza vaccine, using the strain composition 2009/2010

Trial Locations (3)

35033

Site 3, Marburg

35392

Site 2, Giessen

35745

Site 1, Herborn

Sponsors

Lead Sponsor

Novartis

Collaborators (1)

Novartis Vaccines
All Listed Sponsors
collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY